Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Evolution and Predictive Factors of Improvement of Obstructive Sleep Apnea in an Obese Population After Bariatric Surgery.

Magne F, Gomez E, Marchal O, Malvestio P, Reibel N, Brunaud L, Ziegler O, Quilliot D, Chabot F, Chaouat A.

J Clin Sleep Med. 2019 Oct 15;15(10):1509-1516. doi: 10.5664/jcsm.7988.

PMID:
31596217
2.

Evolution and Predictive Factors of Improvement of Obstructive Sleep Apnea in an Obese Population After Bariatric Surgery.

Magne F, Gomez E, Marchal O, Malvestio P, Reibel N, Brunaud L, Ziegler O, Quilliot D, Chabot F, Chaouat A.

J Clin Sleep Med. 2019 Sep 12. pii: jc-19-00119. [Epub ahead of print]

PMID:
31513528
3.

T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease.

Maurac A, Lardenois É, Eyries M, Ghigna MR, Petit I, Montani D, Guillaumot A, Caput B, Chabot F, Chaouat A.

Eur Respir J. 2019 Aug 22;54(2). pii: 1900388. doi: 10.1183/13993003.00388-2019. Print 2019 Aug. No abstract available.

PMID:
31164435
4.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center.

Carette H, Zysman M, Morelot-Panzini C, Perrin J, Gomez E, Guillaumot A, Burgel PR, Deslee G, Surpas P, Le Rouzic O, Perez T, Chaouat A, Roche N, Chabot F; Initiatives BPCO (bronchopneumopathie chronique obstructive) Scientific Committee and Investigators.

BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.

5.

[Early determinants of chronic obstructive pulmonary disease: Lung regeneration, a new therapeutic target?]

Zysman M, Ribeiro Baptista B, Essari LA, Giffard C, Chabot F, Epaud R, Lanone S, Boczkowski J, Boyer L.

Rev Mal Respir. 2019 Apr;36(4):447-450. doi: 10.1016/j.rmr.2019.03.006. Epub 2019 Apr 19. French.

PMID:
31010755
6.

[A case of bronchiectasis due to light chain deposition disease].

Millet F, Gomez E, Hirschi S, Petit I, Chenard MP, Mouget B, Guillaumot A, Chaouat A, Colombat M, Chabot F.

Rev Mal Respir. 2019 Apr;36(4):538-542. doi: 10.1016/j.rmr.2018.11.008. Epub 2019 Jan 24. French.

PMID:
30686554
7.

[Drug-induced interstitial pneumonitis due to avelumab: A case report].

Brie V, Faure M, Garon J, Petit I, Gomez E, Knoepfli A, Decavele M, Petitpain N, Chabot F, Chaouat A.

Rev Mal Respir. 2018 Nov;35(9):978-982. doi: 10.1016/j.rmr.2018.07.005. Epub 2018 Oct 11. French.

PMID:
30318432
8.

Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.

Fauny M, Bauer E, Albuisson E, Perrier-Cornet J, Deibener J, Chabot F, Mandry D, Huttin O, Chary-Valckenaere I, Loeuille D.

Rheumatol Int. 2018 Oct;38(10):1901-1910. doi: 10.1007/s00296-018-4139-5. Epub 2018 Aug 21.

PMID:
30132216
9.

Three-Dimensional Echocardiography for the Assessment of Right Ventriculo-Arterial Coupling.

Aubert R, Venner C, Huttin O, Haine D, Filippetti L, Guillaumot A, Mandry D, Marie PY, Juilliere Y, Chabot F, Chaouat A, Selton-Suty C.

J Am Soc Echocardiogr. 2018 Aug;31(8):905-915. doi: 10.1016/j.echo.2018.04.013. Epub 2018 Jun 27.

PMID:
29958760
10.

Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.

Ribeiro Baptista B, Petitpain N, Gomez E, Yelehé-Okouma M, Valentin S, Guillaumot A, Chabot F, Chaouat A.

Fundam Clin Pharmacol. 2019 Feb;33(1):127-129. doi: 10.1111/fcp.12396. Epub 2018 Jul 15.

PMID:
29956855
11.

[Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].

Chaouat A, Cherifi A, Sitbon O, Girerd N, Zysman M, Faure M, Mandry D, Mercy M, Guillaumot A, Fay R, Marie PY, Chabot F.

Rev Mal Respir. 2018 Sep;35(7):749-758. doi: 10.1016/j.rmr.2018.01.010. Epub 2018 Jun 23. French.

PMID:
29945811
12.

Altered Feeding Behaviors and Adiposity Precede Observable Weight Gain in Young Rats Submitted to a Short-Term High-Fat Diet.

Andrich DE, Melbouci L, Ou Y, Leduc-Gaudet JP, Chabot F, Lalonde F, Lira FS, Gaylinn BD, Gouspillou G, Danialou G, Comtois AS, St-Pierre DH.

J Nutr Metab. 2018 Apr 1;2018:1498150. doi: 10.1155/2018/1498150. eCollection 2018.

13.

[Tunnelled central venous catheter infection during treatment with epoprostenol].

Koszutski M, Faure M, Guillaumot A, Gomez E, Mercy M, Chabot F, Chaouat A.

Rev Mal Respir. 2018 Mar;35(3):324-327. doi: 10.1016/j.rmr.2017.03.037. Epub 2018 Mar 28. French.

PMID:
29602480
14.

The impact of a short-term high-fat diet on mitochondrial respiration, reactive oxygen species production, and dynamics in oxidative and glycolytic skeletal muscles of young rats.

Leduc-Gaudet JP, Reynaud O, Chabot F, Mercier J, Andrich DE, St-Pierre DH, Gouspillou G.

Physiol Rep. 2018 Feb;6(4). doi: 10.14814/phy2.13548.

15.

[Erratum to the abstracts of the scientific communications presented at the 21st Congrès de pneumologie de langue française. January 27-29, 2017, Marseille (France)].

Blanc FX, Dalphin JC, Chabot F.

Rev Mal Respir. 2017 Nov 7:1040-1042. doi: 10.1016/j.rmr.2017.10.002. [Epub ahead of print] French. No abstract available.

PMID:
29126748
16.

Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Société de Pneumologie de Langue Française.

Zysman M, Chabot F, Housset B, Morelot Panzini C, Devillier P, Roche N; Société de Pneumologie de Langue Française.

Eur Respir J. 2017 Oct 12;50(4). pii: 1701250. doi: 10.1183/13993003.01250-2017. Print 2017 Oct. No abstract available.

17.

New guidelines for acute COPD exacerbations.

Jouneau S, Chabot F, Roche N.

Rev Mal Respir. 2017 Apr;34(4):279-281. doi: 10.1016/j.rmr.2017.05.001. No abstract available.

PMID:
28599784
18.

Can MRI detect pulmonary hypertension in a population pre-selected by echocardiography?

Venner C, Odille F, Voilliot D, Chaouat A, Chabot F, Felblinger J, Bonnemains L.

Acta Radiol. 2018 Feb;59(2):180-187. doi: 10.1177/0284185117712541. Epub 2017 Jun 8.

PMID:
28595488
19.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
20.

[What are the definitions of acute COPD exacerbations and COPD decompensations?]

Chabot F.

Rev Mal Respir. 2017 Apr;34(4):327-330. doi: 10.1016/j.rmr.2017.03.002. Epub 2017 May 2. Review. French. No abstract available.

PMID:
28476416
21.

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

Faure M, Gomez E, Dorfmüller P, Mandry D, Canuet M, Kessler R, Chabot F, Chaouat A.

Respir Med Case Rep. 2017 Apr 4;21:74-77. doi: 10.1016/j.rmcr.2017.04.001. eCollection 2017.

22.

Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.

Zuily S, Domingues V, Suty-Selton C, Eschwège V, Bertoletti L, Chaouat A, Chabot F, Regnault V, Horn EM, Erkan D, Wahl D.

Autoimmun Rev. 2017 Jun;16(6):576-586. doi: 10.1016/j.autrev.2017.04.003. Epub 2017 Apr 12. Review.

PMID:
28411166
23.

Erratum to "Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de pneumologie de langue française" [Rev. Mal. Respir. 33 (2016) 911-936].

Zysman M, Chabot F, Devillier P, Housset B, Morelot-Panzini C, Roche N; pour la Société de pneumologie de langue française (SPLF).

Rev Mal Respir. 2017 Feb;34(2):175-176. doi: 10.1016/j.rmr.2017.01.005. Epub 2017 Feb 23. No abstract available.

PMID:
28237069
24.

Occupational Asthma to Detergent Protease Associated With a Late-Phase Neutrophilic Cutaneous Response.

Poussel M, Penven E, Essari LA, Chabot F, Barbaud A, Paris C.

J Investig Allergol Clin Immunol. 2017;27(1):60-62. doi: 10.18176/jiaci.0115. No abstract available.

25.

Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française.

Zysman M, Chabot F, Devillier P, Housset B, Morelot-Panzini C, Roche N; Société de Pneumologie de Langue Française (SPLF).

Rev Mal Respir. 2016 Dec;33(10):911-936. doi: 10.1016/j.rmr.2016.10.004. Epub 2016 Nov 25. Review. Erratum in: Rev Mal Respir. 2017 Feb;34(2):175-176.

PMID:
27890625
26.

[Erratum to the abstracts of the scientific communications presented at the 20th Congrès de pneumologie de langue française. January 29-31, 2016, Lille (France)].

Cuvelier A, Dalphin JC, Chabot F.

Rev Mal Respir. 2016 Nov;33(9):828-830. doi: 10.1016/j.rmr.2016.10.001. Epub 2016 Nov 2. French. No abstract available.

PMID:
27814996
27.

[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].

Huet D, Godbert B, Hermann J, Zordan JM, Chabot F, Andréjak C.

Rev Mal Respir. 2017 Mar;34(3):257-261. doi: 10.1016/j.rmr.2016.05.012. Epub 2016 Sep 14. French.

PMID:
27639948
28.

[Multicystic presentation of a lepidic mucinous adenocarcinoma].

Beurton A, Gomez E, Mandry D, Champigneulle J, Perez P, Chaouat A, Chabot F.

Rev Mal Respir. 2016 Nov;33(9):812-816. doi: 10.1016/j.rmr.2016.04.028. Epub 2016 Jul 18. French.

PMID:
27444696
29.

[Updated guidelines for management and monitoring of asthmatic patients: The Société de pneumologie de langue française maintains the control].

Didier A, Chabot F.

Rev Mal Respir. 2016 Apr;33(4):269-70. doi: 10.1016/j.rmr.2016.04.024. French. No abstract available.

PMID:
27233624
30.

[Alpha-1 antitrypsin deficiency caused by Null mutation].

Perrin J, Aimone-Gastin I, Balduyck M, Mercy M, Filhine-Trésarrieu P, Odou MF, Chaouat A, Chabot F.

Rev Mal Respir. 2016 Sep;33(7):612-7. doi: 10.1016/j.rmr.2015.10.007. Epub 2015 Nov 18. French.

PMID:
26604020
31.

Occupational asthma to "the miracle tree" (Moringa oleifera): first description.

Poussel M, Penven E, Richard C, Jacquenet S, Chabot F, Paris C.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):813-4. doi: 10.1016/j.jaip.2015.05.016. Epub 2015 Jun 25. No abstract available.

PMID:
26116950
32.

Lack of Transcription Factor p53 Exacerbates Elastase-Induced Emphysema in Mice.

Chrusciel S, Zysman M, Caramelle P, Tiendrebeogo A, Baskara I, Le Gouvello S, Chabot F, Giraudier S, Boczkowski J, Boyer L.

Am J Respir Cell Mol Biol. 2016 Feb;54(2):188-99. doi: 10.1165/rcmb.2014-0375OC.

PMID:
26106979
33.

Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level.

Poussel M, Thil C, Kaminsky P, Mercy M, Gomez E, Chaouat A, Chabot F, Chenuel B.

Neuromuscul Disord. 2015 May;25(5):403-8. doi: 10.1016/j.nmd.2015.02.006. Epub 2015 Feb 17.

PMID:
25753091
34.

[Impact of COPD: from disability to exacerbations].

Chabot F, Zysman M, Perrin J, Mercy M, Guillaumot A, Gomez E, Kheir A, Chaouat A.

Presse Med. 2014 Dec;43(12 Pt 1):1353-8. doi: 10.1016/j.lpm.2014.08.009. Epub 2014 Oct 29. Review. French.

PMID:
25448123
35.

Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

Chabot F, Caron A, Laplante M, St-Pierre DH.

World J Diabetes. 2014 Jun 15;5(3):328-41. doi: 10.4239/wjd.v5.i3.328. Review.

36.

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.

Chaouat A, Sitbon O, Mercy M, Ponçot-Mongars R, Provencher S, Guillaumot A, Gomez E, Selton-Suty C, Malvestio P, Regent D, Paris C, Hervé P, Chabot F.

Eur Respir J. 2014 Sep;44(3):704-13. doi: 10.1183/09031936.00153613. Epub 2014 May 15.

37.

[Bronchioloalveolar carcinoma: an exceptional cause of diffuse lung disease in a patient with acute myeloid leukemia].

Boubaya A, Gomez E, Guerder A, Ropion-Michaux H, Kheir A, Vignaud JM, Chaouat A, Chabot F.

Rev Mal Respir. 2014 Mar;31(3):259-62. doi: 10.1016/j.rmr.2013.07.003. Epub 2013 Aug 23. French.

PMID:
24680118
38.

[Pulmonary function tests in COPD].

Chabot F, Didier A, Housset B.

Rev Mal Respir. 2014 Jan;31(1):6-7. doi: 10.1016/j.rmr.2014.01.003. French. No abstract available.

PMID:
24461436
39.

Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.

Cracowski JL, Chabot F, Labarère J, Faure P, Degano B, Schwebel C, Chaouat A, Reynaud-Gaubert M, Cracowski C, Sitbon O, Yaici A, Simonneau G, Humbert M.

Eur Respir J. 2014 Mar;43(3):915-7. doi: 10.1183/09031936.00151313. Epub 2013 Nov 14. No abstract available.

40.

[Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan].

Ponçot-Mongars R, Zysman M, Regent D, Gomez E, Chaouat A, Chabot F.

Rev Mal Respir. 2013 Mar;30(3):222-6. doi: 10.1016/j.rmr.2012.06.002. Epub 2012 Jul 23. French.

PMID:
23497932
41.

Plasma levels of high-density lipoprotein cholesterol are not associated with survival in pulmonary arterial hypertension.

Cracowski JL, Labarère J, Renversez JC, Degano B, Chabot F, Humbert M.

Am J Respir Crit Care Med. 2012 Jul 1;186(1):107; author reply 107-8. No abstract available.

PMID:
22753690
42.

Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.

Cracowski JL, Degano B, Chabot F, Labarère J, Schwedhelm E, Monneret D, Iuliano L, Schwebel C, Chaouat A, Reynaud-Gaubert M, Faure P, Maas R, Renversez JC, Cracowski C, Sitbon O, Yaïci A, Simonneau G, Humbert M.

Chest. 2012 Oct;142(4):869-876. doi: 10.1378/chest.11-1267.

PMID:
22406961
43.

[Chronic respiratory failure].

Chaouat A, Gomez E, Chabot F.

Rev Prat. 2011 Nov;61(9):1283-90. French. No abstract available.

PMID:
22308823
44.

Giant cell interstitial pneumonia: report of two cases with high titanium concentration in the lung.

Paris C, Pairon JC, Billon-Galland MA, Vanoni-Espiand H, Godbert B, Martinet Y, Chabot F, Aymard B, Vignaud JM.

Am J Respir Crit Care Med. 2011 Dec 1;184(11):1315-7. No abstract available.

PMID:
22162891
45.

[Symptoms and natural history of COPD: role of the distal airways].

Chaouat A, Chabot F, Dusser D.

Rev Mal Respir. 2011 Oct;28(8):1071-8. doi: 10.1016/j.rmr.2011.08.004. Epub 2011 Oct 28. Review. French.

PMID:
22099412
46.

[What are the mechanisms of breathlessness in COPD?].

Chaouat A, Gomez E, Guillaumot A, Chabot F.

Rev Prat. 2011 Jun;61(6):787. French. No abstract available.

PMID:
21826925
47.

[Disproportionate pulmonary hypertension in COPD].

Guillaumot A, Gomez E, Chaouat A, Chabot F.

Rev Prat. 2011 Jun;61(6):788. French. No abstract available.

PMID:
21826924
48.

[What are the mechanisms of obstruction in COPD?].

Gomez E, Guillaumot A, Chaouat A, Chabot F.

Rev Prat. 2011 Jun;61(6):784-5. French. No abstract available.

PMID:
21826923
49.

[Classification of COPD and prognostic factors].

Chabot F, Gomez E, Guillaumot A, Chaouat A.

Rev Prat. 2011 Jun;61(6):783. French. No abstract available.

PMID:
21826922
50.

[From COPD to chronic respiratory failure].

Chabot F, Gomez E, Guillaumot A, Chaouat A.

Rev Prat. 2011 Jun;61(6):781-6. French.

PMID:
21826921

Supplemental Content

Loading ...
Support Center